Solid biosciences reports inducement grant to new senior vice president, clinical development

Cambridge, mass., july 02, 2021 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy (duchenne), today announced the grant of an inducement award to its newly appointed senior vice president, clinical development, roxana dreghici. the grant was approved by a majority of the independent directors of the company on june 16, 2021 as an inducement material to dr. dreghici entering into employment with the company in accordance with nasdaq listing rule 5635(c)(4).
SLDB Ratings Summary
SLDB Quant Ranking